GC Medical Science Corporation (KOSDAQ:142280)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,930.00
+30.00 (1.03%)
At close: Aug 11, 2026

GC Medical Science Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
105,483108,413103,85294,011113,109101,675
Revenue Growth
-1.08%4.39%10.47%-16.89%11.25%-10.32%
Gross Profit
14,41415,02214,76713,95512,7461,631
Operating Income
2,6842,8872,2611,272-1,808-20,164
Net Income
4,4733,6663,5811,797-3,581-21,202
Earnings Per Share
172.25145.7541.0475.80-170.00-1006.40
EPS Growth
2594.80%255.16%-45.86%---

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Green Cross MS Co., Ltd.
105,885109,122104,60094,066110,820100,829
Green Cross Medis Co., Ltd.
15,45515,83313,16311,75614,88412,789
Consolidated Adjustments
-15,857-16,541-13,911-11,811-12,595-11,944
Total
105,483108,413103,85294,011113,109101,675

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
956.1372.63678.495,74410,7511,843
Total Debt
19,42217,45417,35322,58023,40136,981
Net Cash (Debt)
-18,466-17,081-16,675-16,836-12,650-35,139
Net Cash Growth
------
Net Cash Per Share
-690.93-640.31-623.49-629.11-600.13-1667.93

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
7,0157,1963,6614,24110,880-18,195
Capital Expenditures
-3,768-4,720-3,216-5,632-3,426-3,598
Free Cash Flow
3,2472,476445.24-1,3917,454-21,793
Free Cash Flow Growth
-456.00%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
13.66%13.86%14.22%14.84%11.27%1.60%
Operating Margin
2.54%2.66%2.18%1.35%-1.60%-19.83%
Pretax Margin
2.84%1.90%3.27%1.98%-2.61%-20.76%
Profit Margin
4.24%3.38%3.45%1.91%-3.17%-20.85%
FCF Margin
3.08%2.28%0.43%-1.48%6.59%-21.43%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
17.0123.7521.7055.95--
Forward PE
-34.2434.2434.2434.2434.24
P/FCF Ratio
19.6235.17174.54-16.35-
PS Ratio
0.600.800.751.071.081.50